dc.contributor.author | O'Sullivan, J. | |
dc.contributor.author | Leblond, A. | |
dc.contributor.author | Metharom, Pat | |
dc.contributor.author | Kumar, A. | |
dc.contributor.author | Kelly, G. | |
dc.contributor.author | Hristova, E. | |
dc.contributor.author | Hynes, B. | |
dc.contributor.author | O'Connor, R. | |
dc.contributor.author | Caplice, N. | |
dc.date.accessioned | 2017-09-27T10:21:33Z | |
dc.date.available | 2017-09-27T10:21:33Z | |
dc.date.created | 2017-09-27T09:48:04Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | O'Sullivan, J. and Leblond, A. and Metharom, P. and Kumar, A. and Kelly, G. and Hristova, E. and Hynes, B. et al. 2011. POTENT CARDIOPROTECTIVE EFFECTS OF LOW DOSE INSULIN-LIKE GROWTH FACTOR-1 (LD-IGF-1) TREATMENT POST MYOCARDIAL INFARCTION ARE MEDIATED THROUGH PHOSPHORYLATION OF THE IGF-1 RECEPTOR, GSK-3BETA INHIBITION AND SURVIVAL KINASE UPREGULATION, 60th Annual Scientific Session and Expo of the American-College-of-Cardiology, pp. E2050-E2050. | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/56924 | |
dc.title | POTENT CARDIOPROTECTIVE EFFECTS OF LOW DOSE INSULIN-LIKE GROWTH FACTOR-1 (LD-IGF-1) TREATMENT POST MYOCARDIAL INFARCTION ARE MEDIATED THROUGH PHOSPHORYLATION OF THE IGF-1 RECEPTOR, GSK-3BETA INHIBITION AND SURVIVAL KINASE UPREGULATION | |
dc.type | Conference Paper | |
dcterms.source.volume | 57 | |
dcterms.source.startPage | E2050 | |
dcterms.source.endPage | E2050 | |
dcterms.source.issn | 0735-1097 | |
dcterms.source.title | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | |
dcterms.source.series | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | |
dcterms.source.conference | 60th Annual Scientific Session and Expo of the American-College-of-Cardiology | |
curtin.accessStatus | Fulltext not available | |
curtin.faculty | Faculty of Health Sciences | |